Publications by authors named "Clara D Bloomfield"

Claim this Profile
R
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study.
Marlise R Luskin, Jun Yin, Gerard Lozanski, Emily Curran, Gregory Malnassy, Clara D Bloomfield

Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.
Nikolaus Jahn, Ekaterina Jahn, Maral Saadati, Lars Bullinger, Richard A Larson, Clara D Bloomfield

Leukemia· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia.
Dimitrios Papaioannou, Hatice G Ozer, Deedra Nicolet, Amog P Urs, Tobias Herold, Clara D Bloomfield

Haematologica· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results.
Frank G Rücker, Ling Du, Tamara J Luck, Axel Benner, Julia Krzykalla, Clara D Bloomfield

Leukemia· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq.
Caner Saygin, Eileen Hu, Pu Zhang, Steven Sher, Arletta Lozanski, Clara D Bloomfield

Leukemia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq.
Caner Saygin, Eileen Hu, Pu Zhang, Steven Sher, Arletta Lozanski, Clara D Bloomfield

Leukemia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.
Francesca Ferraro, Christopher A Miller, Keegan A Christensen, Nichole M Helton, Margaret O'Laughlin, Clara D Bloomfield

Proc Natl Acad Sci U S A· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13.
Costanza Zanetti, Rahul Kumar, Joscha Ender, Parimala S Godavarthy, Mark Hartmann, Clara D Bloomfield

Blood· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.
Richard A Larson, Sumithra J Mandrekar, Lucas J Huebner, Ben L Sanford, Kristina Laumann, Clara D Bloomfield

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement.
Marius Bill, Krzysztof Mrózek, Brian Giacopelli, Jessica Kohlschmidt, Deedra Nicolet, Clara D Bloomfield

J Hematol Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).
Alison R Walker, Guido Marcucci, Jun Yin, William Blum, Wendy Stock, Clara D Bloomfield

Blood Adv· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin.
Laura K Schmalbrock, Anna Dolnik, Sibylle Cocciardi, Eric Sträng, Frauke Theis, Clara D Bloomfield

Blood· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A precision medicine classification for treatment of acute myeloid leukemia in older patients.
Alice S Mims, Jessica Kohlschmidt, Uma Borate, James S Blachly, Shelley Orwick, Clara D Bloomfield

J Hematol Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia.
Brian Giacopelli, Min Wang, Ada Cleary, Yue-Zhong Wu, Anna Reister Schultz, Clara D Bloomfield

Genome Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21).
Se Young Han, Krzysztof Mrózek, Jenna Voutsinas, Qian Wu, Elizabeth A Morgan, Clara D Bloomfield

Blood Adv· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations.
Alice S Mims, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, Krzysztof Mrόzek, James S Blachly, Clara D Bloomfield

Leukemia· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia.
Christopher J Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, Deedra Nicolet, Jessica Kohlschmidt, Clara D Bloomfield

Blood Adv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years.
Ann-Kathrin Eisfeld, Jessica Kohlschmidt, Alice Mims, Deedra Nicolet, Christopher J Walker, Clara D Bloomfield

Leukemia· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/.
Marius Bill, Krzysztof Mrózek, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, Christopher J Walker, Clara D Bloomfield

Proc Natl Acad Sci U S A· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial.
Maria Teresa Voso, Richard A Larson, Dan Jones, Guido Marcucci, Thomas Prior, Clara D Bloomfield

Blood Adv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia.
Dimitrios Papaioannou, Andreas Petri, Oliver M Dovey, Sara Terreri, Eric Wang, Clara D Bloomfield

Nat Commun· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801.
Guido Marcucci, Susan Geyer, Kristina Laumann, Weiqiang Zhao, Donna Bucci, Clara D Bloomfield

Blood Adv· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.
Konstanze Döhner, Christian Thiede, Nikolaus Jahn, Ekaterina Panina, Agnes Gambietz, Clara D Bloomfield

Blood· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia.
Dimitrios Papaioannou, Andreas Petri, Oliver M Dovey, Sara Terreri, Eric Wang, Clara D Bloomfield

Nat Commun· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and functional significance of circular RNAs in cytogenetically normal AML.
Dimitrios Papaioannou, Stefano Volinia, Deedra Nicolet, Michał Świerniak, Andreas Petri, Clara D Bloomfield

Blood Adv· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis